Accordingly, P2X7 receptors are potential therapeutic candidates for rheumatoid arthritis, hypertension, and atherosclerosis13, 14, and clinical trials of chemical compounds targeting P2X7 have been conducted for P2X7-associated diseases15. The gene discussed is P2RX7; the disease is rheumatoid arthritis.